$UNH
UNITEDHEALTH GROUP INC

2023 Q3 Form 10-Q Financial Statement

#000073176623000053 Filed on August 02, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2
Revenue $92.36B $92.90B
YoY Change 14.18% 15.65%
Cost Of Revenue $9.423B $9.748B
YoY Change 13.45% 13.4%
Gross Profit $82.94B $83.16B
YoY Change 14.26% 15.92%
Gross Profit Margin 89.8% 89.51%
Selling, General & Admin $13.86B $13.81B
YoY Change 18.79% 17.93%
% of Gross Profit 16.71% 16.61%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $1.007B $1.021B
YoY Change 21.62% 27.31%
% of Gross Profit 1.21% 1.23%
Operating Expenses $13.86B $13.81B
YoY Change -81.13% 17.93%
Operating Profit $8.526B $8.057B
YoY Change 14.26% 12.97%
Interest Expense $834.0M $828.0M
YoY Change -261.63% 77.3%
% of Operating Profit 9.78% 10.28%
Other Income/Expense, Net
YoY Change
Pretax Income $7.692B $7.229B
YoY Change 10.74% 8.46%
Income Tax $1.654B $1.572B
% Of Pretax Income 21.5% 21.75%
Net Earnings $5.841B $5.474B
YoY Change 11.0% 7.97%
Net Earnings / Revenue 6.32% 5.89%
Basic Earnings Per Share $6.31 $5.89
Diluted Earnings Per Share $6.24 $5.82
COMMON SHARES
Basic Shares Outstanding 926.3M shares 931.0M shares
Diluted Shares Outstanding 936.0M shares 940.0M shares

Balance Sheet

Concept 2023 Q3 2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $38.92B $41.81B
Short-Term Investments
Other Short-Term Assets $5.767B $5.884B
YoY Change 1.94% 12.76%
Inventory
Prepaid Expenses
Receivables $20.67B $17.95B
Other Receivables $17.75B $16.13B
Total Short-Term Assets $91.91B $22.02B
YoY Change 10.81% -67.79%
LONG-TERM ASSETS
Property, Plant & Equipment $11.07B $10.93B
YoY Change 16.91% 15.97%
Goodwill $101.7B $101.7B
YoY Change 21.21% 20.81%
Intangibles $15.20B $15.64B
YoY Change 40.94% 38.62%
Long-Term Investments $1.400B $50.45B
YoY Change -96.63% 2867.88%
Other Assets $16.71B $16.07B
YoY Change 15.95% 10.64%
Total Long-Term Assets $190.2B $258.1B
YoY Change 18.75% 59.53%
TOTAL ASSETS
Total Short-Term Assets $91.91B $22.02B
Total Long-Term Assets $190.2B $258.1B
Total Assets $282.1B $280.2B
YoY Change 16.04% 21.72%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $31.16B $29.52B
YoY Change 14.44% 17.38%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $2.600B $4.400B
YoY Change
Long-Term Debt Due $2.690B $1.921B
YoY Change -16.69% -65.65%
Total Short-Term Liabilities $114.2B $35.84B
YoY Change 13.12% -59.6%
LONG-TERM LIABILITIES
Long-Term Debt $58.08B $59.27B
YoY Change 27.82% 29.41%
Other Long-Term Liabilities $13.62B $43.61B
YoY Change -83.48% 264.39%
Total Long-Term Liabilities $71.69B $102.9B
YoY Change -43.92% 78.09%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.2B $35.84B
Total Long-Term Liabilities $71.69B $102.9B
Total Liabilities $188.1B $197.8B
YoY Change 13.99% 32.72%
SHAREHOLDERS EQUITY
Retained Earnings $93.17B $89.99B
YoY Change 11.29% 11.74%
Common Stock $9.000M $9.000M
YoY Change -10.0% -10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $84.49B $82.35B
YoY Change
Total Liabilities & Shareholders Equity $282.1B $280.2B
YoY Change 16.04% 21.72%

Cashflow Statement

Concept 2023 Q3 2023 Q2
OPERATING ACTIVITIES
Net Income $5.841B $5.474B
YoY Change 11.0% 7.97%
Depreciation, Depletion And Amortization $1.007B $1.021B
YoY Change 21.62% 27.31%
Cash From Operating Activities $6.902B $11.03B
YoY Change -62.79% 60.56%
INVESTING ACTIVITIES
Capital Expenditures $838.0M $829.0M
YoY Change -215.75% -226.18%
Acquisitions
YoY Change
Other Investing Activities -$1.801B $101.0M
YoY Change 1364.23% -101.27%
Cash From Investing Activities -$2.639B -$728.0M
YoY Change 211.57% -91.52%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -7.104B -10.46B
YoY Change 107.96% -1205.6%
NET CHANGE
Cash From Operating Activities 6.902B 11.03B
Cash From Investing Activities -2.639B -728.0M
Cash From Financing Activities -7.104B -10.46B
Net Change In Cash -2.841B -155.0M
YoY Change -119.89% -79.87%
FREE CASH FLOW
Cash From Operating Activities $6.902B $11.03B
Capital Expenditures $838.0M $829.0M
Free Cash Flow $6.064B $10.20B
YoY Change -68.54% 35.53%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0 shares
CY2022Q4 unh Investments Amortized Cost
InvestmentsAmortizedCost
46622000000 usd
CY2022Q4 unh Investments Gross Unrealized Gains
InvestmentsGrossUnrealizedGains
59000000 usd
CY2022Q4 unh Investments Gross Unrealized Losses
InvestmentsGrossUnrealizedLosses
3681000000 usd
CY2022Q4 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
43000000000 usd
CY2023Q2 unh Investments Amortized Cost
InvestmentsAmortizedCost
48298000000 usd
CY2023Q2 unh Investments Gross Unrealized Gains
InvestmentsGrossUnrealizedGains
26000000 usd
CY2023Q2 unh Investments Gross Unrealized Losses
InvestmentsGrossUnrealizedLosses
3470000000 usd
CY2023Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
44854000000 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Into Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3
0 usd
us-gaap Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Asset Transfers Out Of Level3
FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3
0 usd
us-gaap Other Commitments Description
OtherCommitmentsDescription
As of June 30, 2023, the Company has entered into agreements to acquire companies in the health care sector, subject to regulatory approval and other customary closing conditions.
CY2023Q2 us-gaap Other Commitment
OtherCommitment
5000000000 usd
us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
8200000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents
104000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Receivables
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables
550000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipment
542000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
1795000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssets
2991000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther
1000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable
473000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Noncurrent Liabilities Other
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNoncurrentLiabilitiesOther
617000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilities
1091000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet
1900000000 usd
us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
7734000000 usd
CY2023Q2 unh Business Combinations Redeemable Noncontrolling Interests
BusinessCombinationsRedeemableNoncontrollingInterests
113000000 usd
CY2023Q2 unh Business Combinations Nonredeemable Noncontrolling Interests
BusinessCombinationsNonredeemableNoncontrollingInterests
1297000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Less Noncontrolling Interest
BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedLessNoncontrollingInterest
8224000000 usd
us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
432000000 usd
us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P9Y
us-gaap Indefinitelived Intangible Assets Acquired
IndefinitelivedIntangibleAssetsAcquired
1363000000 usd
CY2023Q2 us-gaap Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill
BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill
1795000000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
4 reportablesegments
CY2023Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1115000000 usd
CY2023Q2 us-gaap Revenues
Revenues
92903000000 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
8057000000 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
828000000 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
7229000000 usd
CY2022Q2 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
295000000 usd
CY2022Q2 us-gaap Revenues
Revenues
80332000000 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
7132000000 usd
CY2022Q2 us-gaap Interest Expense
InterestExpense
467000000 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
6665000000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1913000000 usd
us-gaap Revenues
Revenues
184834000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
16143000000 usd
us-gaap Interest Expense
InterestExpense
1582000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
14561000000 usd
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
662000000 usd
us-gaap Revenues
Revenues
160481000000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
14082000000 usd
us-gaap Interest Expense
InterestExpense
900000000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
13182000000 usd
CY2023Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2023Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000731766-23-000053-index-headers.html Edgar Link pending
0000731766-23-000053-index.html Edgar Link pending
0000731766-23-000053.txt Edgar Link pending
0000731766-23-000053-xbrl.zip Edgar Link pending
ex311unh2023630.htm Edgar Link pending
ex321unh2023630.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
unh-20230630.htm Edgar Link pending
unh-20230630.xsd Edgar Link pending
unh-20230630_g1.jpg Edgar Link pending
unh-20230630_def.xml Edgar Link unprocessable
unh-20230630_lab.xml Edgar Link unprocessable
unh-20230630_pre.xml Edgar Link unprocessable
unh-20230630_htm.xml Edgar Link completed
unh-20230630_cal.xml Edgar Link unprocessable